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Abstract: We explore the use of fiber optic microendoscopy to image and 
quantify bacterial infection in the skin and lungs using an animal model. 
The contact probe fiber bundle fluorescence microendoscope has a 4 µm 
resolution, a 750 µm field of view, and a 1 mm outer diameter. 
Subcutaneous and intra-tracheal infections of fluorescent Mycobacterium 
bovis Bacillus Calmette-Guérin (BCG) bacteria were detected in situ from 
inocula down to 10
4 and 10
7 colony forming units, respectively. 
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1. Introduction 
Bacterial infections, including tuberculosis, affect a large segment of the world’s population. 
Centers for Disease Control estimates indicate one-third of the world’s population is currently 
infected with tuberculosis [1]. The disease has an incubation period that varies from a few 
weeks to years, thereby complicating early stage diagnosis and necessitating a cocktail of 
antibiotics for treatment once it is diagnosed. Study of early stage bacterial pathogenesis, 
particularly in the case of tuberculosis, is imperative to the design of better clinical diagnostic 
and therapeutic techniques to help combat this disease. 
Researchers have developed optical biosensors that can detect bacteria in various ex vivo 
samples [2–4]. Whole body fluorescence imaging scanners [5,6] are also being developed for 
non-invasive, in vivo detection and real-time monitoring of growth using bioluminescent and 
fluorescent versions of bacteria such as Citrobacter rodentium and Escherichia coli [7], 
Staphylococcal aureus [8] and Mycobacterium bovis [9] throughout the body in preclinical 
studies. However, due to the depth of the infected tissue, such as lung tissue in the case of 
tuberculosis, tissue absorption and scattering of photons emitted by the low numbers of 
bacteria present precludes the possibility of using these systems for early stage quantification 
of bacterial infections. Although detection limits for macroscopic imaging systems have been 
reported down to 10
2 colony forming units (CFU) for in vitro samples, 10
5 CFU has been 
reported as a limit of detection for in vivo subcutaneous infections using bioluminescent and 
fluorescent bacteria [8,9]. Owing to the highly light scattering nature of the lungs, pulmonary 
infections with intra-tracheal dosage levels greater than 10
5 CFU are typically employed. 
However, since the infectious dose for tuberculosis is thought to be as low as 1-10 bacteria 
[10], improving this threshold of detection is a high priority. A system that can image and 
quantify pulmonary bacterial infection with intra-tracheal inocula below 10
5 CFU during the 
first few days following infection to model early stage and low bacterial load infections would 
be very valuable for research on infectious diseases. 
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signals from tissues and organs in vivo are in common use in the healthcare sector. Optical 
fiber bundles have been exploited in high resolution confocal microendoscopes [11,12] with 
high numerical aperture miniature objective lenses [13–15]. Simplified contact probe 
microendoscopes with wide-field illumination have more recently been developed [16,17] and 
evaluated as tools for cancer detection [18,19] and brain imaging [20]. Although major 
advances in optical fiber based high resolution in vivo imaging systems have been achieved in 
the field of early cancer detection, to our knowledge, fiber optic microendoscopy has not yet 
been applied to in vivo imaging and detection of bacteria. Such a fiber based fluorescence 
imaging system is uniquely suited for the detection and imaging of small regions of bacterial 
infection inside live animals. It can serve as a valuable tool for study of the early stage in vivo 
dynamics of bacterial infection, especially when used with whole body imaging systems. 
2. Methods 
2.1. Optical system design 
Figure 1 illustrates the layout of the fluorescence microendoscope. The basic design is similar 
to the system developed by Muldoon et al. for early cancer detection in epithelial tissue [16]. 
Excitation and emission wavelengths were selected for detection of fluorescence from 
tdTomato. A light emitting diode (LED) source (Luxeon LumiLED) with a 70 nm bandwidth 
centered at 530 nm is used as an excitation source. The light is collimated by a 10x 
achromatic doublet objective lens (Leica), filtered by a 40 nm bandwidth excitation filter 
(Semrock, FF01-531/40) and dichroic mirror (Semrock, FF562-Di), and focused onto a fiber 
bundle (Sumitomo IGN-08/30) by another 10x objective lens (Leica). The 1 mm outer 
diameter fiber bundle consists of 30,000 individual fibers. The 4 µm nominal fiber core-to-
core spacing determines the system’s resolution, and 750 µm active imaging diameter 
determines the imaging field of view [16]. The fiber bundle transmits the excitation light to its 
distal tip, which is placed directly in contact with the sample. The resulting fluorescence light 
from the sample is collected by the same fiber bundle, filtered by a 54 nm bandwidth emission 
filter (Semrock, FF01-609/54) centered at 609 nm, and imaged onto a scientific grade 1.45 
megapixel CCD camera (QImaging Exi Blue) with 6.45 µm x 6.45 µm pixel size. A 150 mm 
focal length achromatic doublet tube lens (Thorlabs, LSB08-A) and the 10x objective lens 
provide a magnification of 8.2x to focus the entire active imaging diameter of the fiber bundle 
onto the 2/3 inch (diagonal) CCD camera. 
 
Fig. 1. Schematic of fluorescence microendoscope for preclinical imaging. LED: light emitting 
diode, CL: collimating lens, EX: excitation filter, DM: dichroic mirror, OL: objective lens, EM: 
emission filter, FL: focusing lens, CCD: charge coupled device camera. 
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Mycobacterium bovis Bacillus Calmette-Guérin (BCG) bacteria, an attenuated form of the live 
bovine tuberculosis bacillus, Mycobacterium bovis and used as a vaccine for Mycobacterium 
tuberculosis, was used in all the experiments. BCG was chosen for this study for safety 
considerations owing to their lack of virulence in humans. However, their ability to infect and 
persist within mammalian tissue is similar to the pathogenic mycobacteria [21]. BCG bacterial 
colonies expressing the fluorescent protein tdTomato and a negative control of non-
fluorescent BCG with vector backbone were grown in colonies on agar. tdTomato was 
selected as the fluorescent protein because it has a greater quantum yield of 0.69 as compared 
to 0.6 for common fluorescent proteins such as the enhanced form of GFP (EGFP) [22], as 
well as a brightness (product of quantum yield and extinction coefficient) that is 2.8 times 
greater than EGFP [23]. Moreover, being a red-shifted protein, it has the advantage of 
emitting in the 580-700 nm wavelength range, where there is reduced light absorption due to 
hemoglobin in tissue [24]. The probe was placed in contact with the in vitro samples, and the 
fluorescent signal from the bacteria was collected with the fiber bundle and imaged onto the 
CCD. This information was used to characterize the sensitivity for fluorescent bacteria. 
Although individual bacteria would not be resolved by the imaging system, the ability to 
resolve bacterial colonies may indicate sufficient resolution to image regions of bacterial 
infection in tissue. 
2.3. In situ imaging of subcutaneous infection 
All animal studies were approved by the Texas A&M Institutional Animal Care and Use 
Committee. In this study, four female Balb/C mice were anesthetized and subcutaneously 
infected with bacteria in four distinct regions. Two mice were inoculated with 10
6, 10
5, and 
10
4 CFU of fluorescent bacteria expressing tdTomato, and the remaining two mice were 
inoculated with 10
3, 10
2, and 10
1 CFU of bacteria expressing tdTomato. Each mouse was 
additionally inoculated with one negative control (10
6 CFU of non-fluorescent bacteria) to 
differentiate the signal from autofluorescence or background signal. Each inoculation site was 
demarcated with a 1 cm circle on the outside surface of the skin. One day following infection, 
the mice were euthanized and excoriated in the infection zone. The microendoscope images 
the tissue directly in contact with the probe, and therefore, cannot detect the bacteria through 
the thickness of the skin. The skin samples were first imaged using the macroscopic imaging 
system (Caliper LifeSciences IVIS Spectrum) to enable a later comparison with the 
microendoscope system. In situ microendoscopic imaging was performed by placing the 
probe in contact with the underside of the skin (Fig. 2). For each demarcated inoculation site, 
20 images were taken randomly in the 1 cm region using a 100 msec camera exposure and 
gain setting of 6 for all sites. Samples from the prepared inocula were transferred to agar 
plates and incubated for a period of one month to determine the number of bacteria present by 
CFU using visual counting. 
 
Fig. 2. Imaging of excoriated skin using the microendoscope. 
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Eight mice were infected intra-tracheally with bacteria (four mice common to the 
subcutaneous experiments). A catheter was inserted into the trachea of the anesthetized mice 
to administer a bolus containing 10
8, 10
7, or 10
6 CFU of fluorescent bacteria or 10
6 CFU of a 
non-fluorescent control, with two mice per inoculum dose. One day following inoculation, the 
mice were euthanized, and the lungs were removed. The lungs were first imaged using the 
macroscopic imaging system. With the current device, in vivo imaging is not possible due to 
the outer diameter of the fiber bundle and the lack of image guidance. The lungs were 
therefore cut open laterally, exposing the inner sections of the trachea and the lobes. The 
microendoscope probe was placed in contact with the inside surface of the tissue in ten 
random sites each in the trachea and lobes, in order to sample the entire area of the lungs. A 
100 msec camera exposure and gain level setting of 6 were used for all sites. However, due to 
the high concentration of bacteria in the 10
8 CFU inoculated lungs, any images that had 
potential pixel saturation were also acquired with a 50 msec exposure and gain of 6. For 
images acquired at half the exposure time, the corresponding average intensity over the field 
of view was doubled for the quantification study. This was done to facilitate proper 
quantification of these images. Punch biopsies from lung samples were then taken using a 
1mm diameter Miltex biopsy punch for imaging with a confocal microscope. 
2.5. Confocal microscopy of in vitro bacterial samples and punch biopsies of intra-tracheally 
infected lung tissue 
Smear samples of tdTomato expressing bacteria grown on agar were taken on a microscope 
slide for high resolution imaging on a confocal microscope. For the negative control, non-
fluorescent BCG bacteria were imaged. The punch biopsies from the lung samples were fixed 
with 4% paraformaldehyde for 24 hours. The biopsy samples were then washed with 1 × 
phosphate buffer solution (PBS) twice and then transferred to a 30% sucrose solution until the 
samples sank down in the solution. Lung tissue was then placed on cryomold, overlaid with 
optimal cutting temperature (OCT) embedding media, and frozen on dry ice. Following 
cryosectioning of the frozen tissue, the sections were then placed on slides and stained with 
the nucleic acid dye DAPI. After washing with PBS, the slides were dried and mounted for 
viewing by confocal fluorescent microscopy. 
High resolution imaging was performed on the in vitro bacterial smear and lung punch 
biopsy samples with an Olympus IX81 confocal fluorescent microscope using the DAPI, 
TRITC, and phase channels with exposure times of 10, 50, and 400 msec, respectively, at a 40 
× magnification. 
2.6. Image processing and analysis 
Matlab software was used to quantify signal intensity in the microendoscope’s field of view. 
The sub-routine averaged the pixel intensity values in the fiber bundle’s active imaging area 
to give an average fluorescence signal for each raw image. The average and standard 
deviation were calculated for each inoculum. A statistical analysis using a Student’s t-test was 
performed on the data acquired for each inoculum’s signal data set (n = 40, subcutaneous; n = 
20, lung) in comparison to the negative control data. The smallest inoculum whose averaged 
fluorescence signal was statistically higher than the negative control was taken as the system’s 
detection limit. 
Due to the heterogeneity in the bacterial distribution in tissue and the random placement of 
the microendoscope within the region of infection, statistically negative images were removed 
from the data set to evaluate correlation of average signal with bacteria. The average signal 
values from each image that were less than one standard deviation from the mean of the 
negative control were removed for the correlation analysis. The signal values from the 
remaining positive sites were averaged for each inoculum and plotted as a function of 
inoculum CFU (obtained from the plated inoculum titer). A regression fit was performed on 
the data to evaluate the correlation between the average fluorescence signal for each inoculum 
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using the data points remaining for each inoculum. Horizontal error bars were determined by 
computing the standard errors of the CFU counts for each agar-plated inoculum titer after a 
three week incubation period. For the lung experiments, only one set of plated inoculum titers 
were assessed for CFU; therefore, horizontal error bars are not included for fluorescent 
bacteria in Fig. 9(b) below. Since the same negative control was used in the skin and lung 
experiments, a triplicate inoculum titer was available for CFU measurement. As a result, an 
appropriate horizontal error bar for the negative control is included in Fig. 9(b). 
To improve visualization of fluorescent signal in microendoscopic images of bacteria in 
tissue, the contrast and brightness were enhanced using ImageJ software. The dynamic range 
of the 8-bit images (256 gray scales) for the higher inoculum skin samples (Fig. 4) were 
rescaled to 0 to 200 gray scales, the lower inoculum skin images (Fig. 5) were rescaled to 0 to 
60, and the lung images (Fig. 7) were adjusted to 0 to 50 gray scales. Therefore, the images 
within a single figure have been equally adjusted for comparison. Although this enhancement 
can saturate some pixels in the images of high concentration bacteria, the spatial localization 
of bacteria is not affected. Moreover, quantification is not affected by image enhancement, 
since it is performed on the raw data. 
3. Results and Discussion 
3.1. In vitro imaging of bacterial colonies 
To assess the sensitivity of the system to image fluorescent bacteria, colonies of bacteria 
expressing tdTomato were imaged in vitro. Figure 3(a) shows an image of bacteria expressing 
tdTomato. Based on the signal and resolution, the image indicates that bacterial colonies 
expressing tdTomato can be detected and resolved well in vitro. Fluorescent protein colonies 
display strong fluorescent signal in comparison to the control that carries vector alone [Fig. 
3(b)]. Based on these results, tdTomato was used as the fluorescent protein expressed by 
bacteria for subcutaneous and intra-tracheal infection experiments. 
 
Fig. 3. Bacterial colonies grown on agar (a) expressing tdTomato, and (b) negative control 
(BCG carrying the vector backbone). 
3.2. In situ imaging of subcutaneous infection 
Imaging bacteria subcutaneously inoculated beneath the skin of mice provides controlled 
conditions and ease of access for characterizing the sensitivity of this system in mammalian 
tissue. Subcutaneously inoculated fluorescent bacteria expressing tdTomato at concentrations 
ranging from 10
6 to 10
1 CFU were imaged in situ. An image demonstrating greater than 
average signal within the 10
6 CFU inoculated region is shown in Fig. 4(a). Representative  
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Fig. 4. In situ images of sites subcutaneously inoculated with (a) and (b) 10
6, (c) 10
5, and (d) 
10
4 CFU of bacteria expressing tdTomato, and (e) 10
6 CFU of negative control (BCG with 
vector backbone). (f) Macroscopic IVIS image of tissue subcutaneously inoculated with (i) 10
6, 
(ii) 10
5, and (iii) 10
4 CFU of bacteria expressing tdTomato, and (iv) 10
6 CFU of negative 
control (BCG with vector backbone). IVIS image field of view is 6.5 cm and scale bar units are 
(photons/sec/cm
2/sr)/(µW/cm
2). 
images of 10
6, 10
5, and 10
4 CFU sites, with average fluorescence signal within one standard 
deviation of the mean fluorescence for each inoculum, are shown in Figs. 4(b-d), respectively. 
Similarly, a representative image of the negative control is shown in Fig. 4(e). The 
corresponding macroscopic image taken with the IVIS Spectrum is shown in Fig. 4(f).   
 
#142906 - $15.00 USD Received 23 Feb 2011; revised 2 Apr 2011; accepted 4 Apr 2011; published 7 Apr 2011
(C) 2011 OSA 1 May 2011 / Vol. 2,  No. 5 / BIOMEDICAL OPTICS EXPRESS  1127 
Fig. 5. In situ images of sites subcutaneously inoculated with (a) 10
3, (b) 10
2, and (c) 10
1 CFU 
of bacteria expressing tdTomato, and (d) 10
6 CFU of negative control (BCG with vector 
backbone). 
Similarly, representative images of 10
3, 10
2, and 10
1 CFU sites are shown in Figs. 5(a-c), 
respectively, and an image of the negative control is shown in Fig. 5(d). Bacterial infection 
foci are visible at concentrations of fluorescent bacteria from 10
6 to 10
4 CFU; whereas, the 
negative control displays only background autofluorescence. These images are consistent with 
data from the macroscopic system image [Fig. 4(f)]. Tissues that had been inoculated with 
less than 10
5 CFU did not have visible signal when imaged with the IVIS system. For 
bacterial concentrations lower than 10
4 CFU, infection foci appear to be visible down to 10
2 
CFU in microendoscopic images; however it is unclear whether the fluorescence is from 
bacteria or auto-fluorescence, especially at low inocula. 
Due to the heterogeneous distribution of bacteria within the region of inoculation, there is 
significant variability in signal intensity depending on where the 750 µm field of view 
imaging probe is placed. This is demonstrated by the variation in intensity between Figs. 4(a) 
and 4(b), two imaging sites in the region of 10
6 CFU subcutaneous infection. In addition, 
there are imaging locations in close proximity to the site of inoculation that have no detectable 
bacterial signal. In order to average out this variability, 20 images were acquired randomly for 
each 1 cm region surrounding an inoculation site. It is also important to note that the actual 
number of bacteria detected within the fiber bundle’s field of view is significantly less than 
the actual inoculum, since the probe’s field of view is much smaller than the region of 
inoculation and infection. 
To assess the increase in fluorescence signal with increasing inoculum dose and variation 
within the signal intensities of each individual inoculum, the fluorescence intensity of each 
image obtained for the skin samples were averaged over the field of view. The mean of the 
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6(a). After removal of samples that did not have statistically significant signal, the mean 
fluorescence intensity was plotted versus CFU for each inoculum in Fig. 6(b). 
An increasing trend is seen in the average fluorescence intensity with increasing inocula 
levels. A Student’s t-test reveals 10
4 CFU to be the lowest inoculum with a statistically 
significant mean as compared to the negative control (p-value = 0.0176) as shown with a 
single asterisk in Fig. 6(a). The 10
5 and 10
6 CFU show much lower p-values (0.005 and 
0.0004, respectively) as compared to the negative control. According to the statistical 
analysis, we do not find a significant signal for inocula lower than 10
4 CFU; however, what 
appear to be a small number of bacteria in the field of view for lower inocula can be 
visualized. It is possible that signal from bacteria at these lower concentrations is masked by 
tissue autofluorescence. Therefore, this system may be able to qualitatively detect regions of 
infection for 10
3 and 10
2 CFU, but quantitative assessment using our current image analysis is 
only possible at higher inocula. Consequently, our limit of detection of subcutaneous infection 
of fluorescent bacteria using this microendoscope is 10
4 CFU, in comparison to a detection 
limit of 10
5 CFU for the same sample using the IVIS. 
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Fig. 6. Subcutaneous infection. (a) Bar plot of average fluorescence intensity for each 
subcutaneous bacterial inoculum. (b) Regression fit for average fluorescence intensity versus 
CFU levels determined from bacterial inoculum titer. 
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increasing size of the error bars in Fig. 6(a). This variation is visible in different imaging sites 
from the same inoculum dose that display varying sizes of tissue infection foci, as is seen in 
Fig. 4(a) and 4(b). Due to heterogeneity in the local distribution of bacteria and the small field 
of view, variation in numbers of bacteria within the imaging area are expected, but it should 
be possible to control for this variation by sampling more tissue sites. 
A linear regression fit to the average fluorescence values from positive imaging sites for 
each inoculum versus CFU levels obtained from the inocula titer [Fig. 6(b)] has an increasing 
trend with an R
2 value of 0.9953 and a slope p-value of 0.0434. The regression line has a 
slope of 0.00022 ± 0.00012. There is a linear relationship between the average fluorescence 
intensities for each inoculum and bacterial CFU. These observations indicate that this imaging 
system may be capable of measuring bacterial numbers directly in mammalian tissues. 
3.3. In situ imaging of intra-tracheally infected lungs 
The lungs of the mice inoculated with BCG at various concentrations were excised and 
imaged with the microendoscope system. Representative images for 10
8, 10
7, and 10
6 CFU 
sites, with an average fluorescence signal within one standard deviation of the mean 
fluorescence, are shown in Figs. 7(a-c). A representative image of the negative control is 
shown in Fig. 7(d). These images demonstrate that regions of fluorescent bacterial infection 
can be detected in the lung tissue. An increasing trend in fluorescence intensity is visible in  
 
 
Fig. 7. In situ images of lungs intra-tracheally inoculated with (a) 10
8, (b) 10
7, and (c) 10
6 CFU 
of bacteria expressing tdTomato, and (d) 10
6 CFU of bacteria carrying vector alone (negative 
control). 
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Fig. 8. Macroscopic IVIS images of lungs intra-tracheally inoculated with (a) 10
8, (b) 10
7, and 
(c) 10
6 CFU of bacteria expressing tdTomato, and (d) 10
6 CFU of non-fluorescent vector 
backbone (negative control). Field of view is 6.5 cm and scale bar units are 
(photons/sec/cm
2/sr)/(µW/cm
2). 
the images with inocula ranging from 10
6 to 10
8 CFU. The corresponding macroscopic 
fluorescence images are shown in Fig. 8. Bifurcation points in the trachea are seen to have 
high levels of fluorescent bacteria, but bacteria are also more homogeneously distributed in 
deeper regions within the lobes of the lung 
The average fluorescence intensity for each intra-tracheal dose is plotted in Fig. 9(a). An 
inoculum of 10
7 CFU produced a statistically significant signal in the lung (p-value = 0.0048) 
as compared to the negative control. The higher detection limit for bacteria in the lungs is 
most likely due to the greater distribution of bacteria in the lung in comparison to a more 
localized subcutaneous inoculation. Following an intra-tracheal inoculation, bacteria are 
distributed throughout the lung tissue, making localization difficult and offering an important 
potential application for microendoscopic systems. 
Prior to performing a correlation analysis, images within one standard deviation of the 
average intensity of the negative control were removed from the data set for each inocula. 
Although the average signal of all the images acquired from the 10
6 CFU inoculum site was 
not found to be statistically significant, removal of negative images resulted in analysis of 
images with statistically significant signal compared to the negative control (p-value = 
0.0026). The regression fit was performed for data between 10
6 and 10
8 CFU. An increasing 
trend in average fluorescence signal of positive sites for each inoculum versus CFU levels is 
seen in lung tissue [Fig. 9(b)]. The regression fit with an R
2 value of 0.9998 and a slope p-
value of 0.0094 indicate a linear relationship between the average signal for each inoculum 
and CFU levels. The slope of the regression line has a value of 0.0000061 ± 0.0000017. These 
results demonstrate potential for use of this system to image and measure bacterial numbers 
during pulmonary infection for intra-tracheal inocula down to 10
6 CFU. Improvements in 
quantification of signal and quantification of bacteria in small tissue samples may enable 
measurement of bacterial numbers in individual images. 
3.4. Confocal microscopy of in vitro bacterial samples and punch biopsies of intra-tracheally 
infected lung tissue 
Imaging in vitro bacterial smear samples and sections from punch biopsies of infected lung 
tissue was performed with a confocal microscope to provide a high resolution image 
reference.  In vitro samples of tdTomato expressing bacteria were prepared by smearing 
bacteria on glass slides and imaging with a confocal microscope. The results in Fig. 10(a) 
show both isolated and clumps of fluorescent bacteria, 4-6 µm in length, in the TRITC (red) 
channel, while no fluorescence was observed for the negative control in Fig. 10(b). 
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Fig. 9. Lung infection. (a) Bar plot of average fluorescence intensity for each intra-tracheal 
(lung) bacterial inoculum. (b) Regression fit for average fluorescence intensity versus CFU 
determined from bacterial inoculum titer. 
 
Fig. 10. Confocal microscope images of in vitro smear samples prepared using (a) tdTomato 
expressing BCG bacteria and (b) non-fluorescent BCG bacteria 
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The nuclei of cells in lung tissue were counter stained with DAPI for ease of visualization. 
Images of tdTomato expressing bacteria in the TRITC and DAPI + TRITC channels in Figs. 
11(b) and 11(c) reveal fluorescent bacteria lodged within tissue. Bacterial fluorescence is 
absent in the TRITC and DAPI + TRITC channels for images of the non-fluorescent negative 
control in Figs. 11(d)-(f). 
 
Fig. 11. Confocal microscope images of histology slides prepared using punch biopsies of lung 
tissue infected with (a), (b), and (c): tdTomato expressing bacteria; (d), (e), and (f): non-
fluorescent BCG bacteria. (a) and (d): DAPI (blue) channel; (b) and (e): TRITC (red) channel; 
(c) and (f): DAPI + TRITC channels. White arrows indicate tdTomato expressing BCG 
bacteria. 
4. Conclusion 
We have constructed a fluorescence microendoscope with a resolution of 4 µm and a 750 µm 
diameter field-of-view. In vitro imaging of bacteria expressing tdTomato demonstrated the 
system’s capability to detect and resolve bacterial colonies. In situ imaging of mice 
subcutaneously and intra-tracheally infected with bacteria expressing tdTomato confirmed 
similar imaging capability at the tissue level. Well resolved regions of bacterial infection were 
visible for subcutaneous inocula of 10
6 to 10
4 CFU and intra-tracheal inocula of 10
8 to 10
6 
CFU. The average fluorescence signal from bacteria in the skin and lung images have a linear 
relationship with CFU, suggesting the potential of this system to obtain quantitative data. This 
is confirmed with the increasing trend seen in the bar plots for the average fluorescence versus 
inoculum dose as well as the linear trends for the average fluorescence versus CFU from 
inoculum titer. 
Based on statistical analysis of the quantified images, the microendoscope’s limit of 
detection was determined to be 10
4 CFU in the case of skin samples and 10
7 CFU for lung 
samples. It is possible that bacteria can be detected qualitatively at inocula down to 10
2 CFU 
in skin, but bacterial detection may be confused with anatomical features that contribute to 
autofluorescence. Additionally, bacteria were qualitatively visible in lungs intra-tracheally 
infected with 10
6 CFU of fluorescent bacteria, which was the lowest inoculum tested in this 
experiment. Improvements in image analysis may lower the level of detection. 
Images of in situ lung tissue infected with fluorescent bacteria display regions of 
significant fluorescence as compared to that infected with non-fluorescent bacteria. In 
addition, there is a linear relationship between the average fluorescence for each inoculum and 
the CFU inoculated. High resolution confocal images of punch biopsies from infected lung 
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microendoscope’s in situ imaging results provide proof of concept and suggest that this device 
shows promise for in vivo imaging using a smaller fiber bundle that can be delivered directly 
into the lungs via a catheter. Initially, in vivo imaging of higher inoculation doses may be 
guided by whole body fluorescence imaging scanners. Subsequently, imaging of infection of 
bacterial concentrations below the detection limit of the whole body scanners may be 
possible. Another potential application for this microendoscope is the imaging and detection 
of bacteria in bronchial washings, which are typically analyzed via microscopic analysis for 
the diagnosis of pulmonary tuberculosis infections [25,26]. Since our system relies on 
fluorescence from the genetically-modified bacteria for detection and bacteria extracted from 
bronchial washings are non-fluorescent, bacteria may be detected via fluorescent reporters. 
One possible method is the use of fluorogenic substrate probes to detect endogenous β-
lactamase enzyme, which is naturally expressed by Mycobacterium tuberculosis, in a reporter 
enzyme fluorescence scheme [27]. 
Use of a microendoscope may provide the capability to image fluorescent bacteria directly 
within its host environment to better understand disease progression. Modification of the 
system for dual channel imaging of cells expressing GFP and bacteria expressing tdTomato 
may enable detailed investigation of cells that phagocytose bacteria and their dynamics in 
vivo. This may aid in visualizing and gaining insight into how bacteria at low inocula 
concentrations from the lungs, the site of initial infection by tuberculosis, spread into extra-
pulmonary regions, the details of which are currently not well understood. 
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